Literature DB >> 18991950

Protein kinases and addiction.

Anna M Lee1, Robert O Messing.   

Abstract

Although drugs of abuse have different chemical structures and interact with different protein targets, all appear to usurp common neuronal systems that regulate reward and motivation. Addiction is a complex disease that is thought to involve drug-induced changes in synaptic plasticity due to alterations in cell signaling, gene transcription, and protein synthesis. Recent evidence suggests that drugs of abuse interact with and change a common network of signaling pathways that include a subset of specific protein kinases. The best studied of these kinases are reviewed here and include extracellular signal-regulated kinase, cAMP-dependent protein kinase, cyclin-dependent protein kinase 5, protein kinase C, calcium/calmodulin-dependent protein kinase II, and Fyn tyrosine kinase. These kinases have been implicated in various aspects of drug addiction including acute drug effects, drug self-administration, withdrawal, reinforcement, sensitization, and tolerance. Identifying protein kinase substrates and signaling pathways that contribute to the addicted state may provide novel approaches for new pharmacotherapies to treat drug addiction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991950      PMCID: PMC3050040          DOI: 10.1196/annals.1441.022

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  283 in total

1.  Atypical protein kinase C is a novel mediator of dopamine-enhanced firing in nucleus accumbens neurons.

Authors:  F Woodward Hopf; William S Mailliard; Gilda F Gonzalez; Ivan Diamond; Antonello Bonci
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

2.  Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates.

Authors:  Lu Pu; Guo-Bin Bao; Nan-Jie Xu; Lan Ma; Gang Pei
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

3.  Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway.

Authors:  Pushkar Sharma; Monica Sharma; Niranjana D Amin; Ram K Sihag; Philip Grant; Natalie Ahn; Ashok B Kulkarni; Harish C Pant
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

4.  Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission.

Authors:  E Valjent; C Pagès; M Rogard; M J Besson; R Maldonado; J Caboche
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

5.  Cocaine-responsive gene expression changes in rat hippocampus.

Authors:  W M Freeman; K Brebner; W J Lynch; D J Robertson; D C Roberts; K E Vrana
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism.

Authors:  H Eilers; E Schaeffer; P E Bickler; J R Forsayeth
Journal:  Mol Pharmacol       Date:  1997-12       Impact factor: 4.436

Review 7.  Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.

Authors:  E Hermans; R A Challiss
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

Review 8.  A decade of CDK5.

Authors:  R Dhavan; L H Tsai
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

Review 9.  Nicotine addiction: the possible role of functional upregulation.

Authors:  Bruno Buisson; Daniel Bertrand
Journal:  Trends Pharmacol Sci       Date:  2002-03       Impact factor: 14.819

10.  Ethanol consumption and behavioral impulsivity are increased in protein kinase Cgamma null mutant mice.

Authors:  B J Bowers; J M Wehner
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more
  40 in total

1.  Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats.

Authors:  Soledad Cabeza de Vaca; Xing-Xiang Peng; Seth Concors; Casey Farin; Elena Lascu; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2011-12-07       Impact factor: 4.530

2.  Substance abuse may be a risk factor for earlier onset of Huntington disease.

Authors:  Joanne A Byars; Leigh J Beglinger; David J Moser; Pedro Gonzalez-Alegre; Peg Nopoulos
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

3.  CaMKII activation is a novel effector of alcohol's neurotoxicity in neural crest stem/progenitor cells.

Authors:  Ana Garic; George R Flentke; Ed Amberger; Marcos Hernandez; Susan M Smith
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

4.  Role of CA2+/calmodulin on ethanol neurobehavioral effects.

Authors:  Pablo Baliño; Juan Carlos Ledesma; Carlos M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2014-05-23       Impact factor: 4.530

5.  Identification of 3-hydroxy-2-(3-hydroxyphenyl)-4H-1-benzopyran-4-ones as isoform-selective PKC-zeta inhibitors and potential therapeutics for psychostimulant abuse.

Authors:  Langtian Yuan; Jin-Soo Seo; Nam Sook Kang; Shahar Keinan; Sarah E Steele; Gregory A Michelotti; William C Wetsel; David N Beratan; Young-Dae Gong; Tong H Lee; Jiyong Hong
Journal:  Mol Biosyst       Date:  2009-05-08

6.  PKMζ maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex.

Authors:  Ying-Ying He; Yan-Xue Xue; Ji-Shi Wang; Qin Fang; Jian-Feng Liu; Li-Fen Xue; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2011-06-01       Impact factor: 7.853

Review 7.  Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice.

Authors:  Michael Foster Olive; Philip M Newton
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

8.  CaMKII represses transcriptionally active β-catenin to mediate acute ethanol neurodegeneration and can phosphorylate β-catenin.

Authors:  George R Flentke; Ana Garic; Marcos Hernandez; Susan M Smith
Journal:  J Neurochem       Date:  2013-10-24       Impact factor: 5.372

9.  Group I metabotropic glutamate receptor-mediated activation of PKC gamma in the nucleus accumbens core promotes the reinstatement of cocaine seeking.

Authors:  Heath D Schmidt; Blake A Kimmey; Adrian C Arreola; R Christopher Pierce
Journal:  Addict Biol       Date:  2014-02-09       Impact factor: 4.280

Review 10.  Therapeutic efficacy of environmental enrichment for substance use disorders.

Authors:  Ewa Galaj; Eddy D Barrera; Robert Ranaldi
Journal:  Pharmacol Biochem Behav       Date:  2019-11-26       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.